Literature DB >> 11318421

Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: application of robotic sample preparation and fast liquid chromatography-mass spectrometry.

K P Bateman1, G Castonguay, L Xu, S Rowland, D A Nicoll-Griffith, N Kelly, C C Chan.   

Abstract

Typically, pharmacokinetic studies in mice require one animal per time point, thus resulting in differences due to dosing error, animal to animal variation and more importantly the euthanasia of a large number of animals. A method for the determination of pharmacokinetic data from serially bled mice to support early drug discovery is described. Sample analysis relies on liquid chromatography coupled with tandem mass spectrometry permitting robust and reproducible analysis requiring approximately 3 min per sample. Several parameters are discussed including the method of sample collection, preparation and analysis. The use of serially bled mice has lead to a remarkable reduction in animal usage and a corresponding reduction in compound required for such experiments. Using conventional methodology, a nine-point pharmacokinetic curve with four animals per time point would require 36 mice. With the method described below, only four mice in total are used and euthanasia is not required, permitting reuse after several weeks recovery and washout. Also, pharmacodynamic-pharmacokinetic correlation is possible and is demonstrated using a mouse model of diabetes.

Entities:  

Mesh:

Year:  2001        PMID: 11318421     DOI: 10.1016/s0378-4347(00)00612-5

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  8 in total

1.  Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies.

Authors:  Enaksha R Wickremsinhe; Everett J Perkins
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

2.  High-throughput pharmacokinetic method: cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysis.

Authors:  Takaho Watanabe; Daniela Schulz; Christophe Morisseau; Bruce D Hammock
Journal:  Anal Chim Acta       Date:  2006-02-10       Impact factor: 6.558

3.  A modified serial blood sampling technique and utility of dried-blood spot technique in estimation of blood concentration: application in mouse pharmacokinetics.

Authors:  Vishwanath Kurawattimath; Krishna Pocha; T Thanga Mariappan; Ravi Kumar Trivedi; Sandhya Mandlekar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-09-25       Impact factor: 2.441

4.  Carotid artery infusions for pharmacokinetic and pharmacodynamic analysis of taxanes in mice.

Authors:  Joely D Jacobs; Elizabeth A Hopper-Borge
Journal:  J Vis Exp       Date:  2014-10-27       Impact factor: 1.355

5.  Reversible cysteine protease inhibitors show promise for a Chagas disease cure.

Authors:  Momar Ndao; Christian Beaulieu; W Cameron Black; Elise Isabel; Fabio Vasquez-Camargo; Milli Nath-Chowdhury; Frédéric Massé; Christophe Mellon; Nathalie Methot; Deborah A Nicoll-Griffith
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

6.  A Simple and Sensitive HPLC Method for Fluorescence Quantitation of Doxorubicin in Micro-volume Plasma: Applications to Pharmacokinetic Studies in Rats.

Authors:  Marjan Daeihamed; Azadeh Haeri; Simin Dadashzadeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

7.  PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1).

Authors:  Jyotica Batra; Jessica Robinson; Christine Mehner; Alexandra Hockla; Erin Miller; Derek C Radisky; Evette S Radisky
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

8.  A fast and cost-effective microsampling protocol incorporating reduced animal usage for time-series transcriptomics in rodent malaria parasites.

Authors:  Abhinay Ramaprasad; Amit Kumar Subudhi; Richard Culleton; Arnab Pain
Journal:  Malar J       Date:  2019-01-25       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.